rss
J Med Genet 2002;39:478-483 doi:10.1136/jmg.39.7.478
  • Original article

Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24

  1. G Brice1,
  2. S Mansour2,
  3. R Bell2,
  4. J R O Collin3,
  5. A H Child1,
  6. A F Brady4,
  7. M Sarfarazi5,
  8. K G Burnand6,
  9. S Jeffery2,
  10. P Mortimer7,
  11. V A Murday2
  1. 1Department of Cardiological Sciences, St George's Medical School, Cranmer Terrace, Tooting, London SW17 0RE, UK
  2. 2Medical Genetics Unit, St George's Medical School, Cranmer Terrace, Tooting, London SW17 0RE, UK
  3. 3Moorfields Eye Hospital, City Road, London EC1V 2PD, UK
  4. 4Kennedy Galton Centre, Northwick Park Hospital, Watford Road, Harrow, UK
  5. 5University of Connecticut Health Center, Farmington, Connecticut, USA
  6. 6Department of Academic Surgery, St Thomas' Hospital, UMDS, London, UK
  7. 7Department of Dermatology, St George's Medical School, Cranmer Terrace, Tooting, London SW17 0RE, UK
  1. Correspondence to:
 Dr S Mansour, South West Thames Regional Genetic Service, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK;
 smansour{at}sghms.ac.uk
  • Accepted 2 April 2002
  • Revised 28 March 2002

Abstract

Introduction: Lymphoedema-distichiasis syndrome (LD) (OMIM 153400) is a rare, primary lymphoedema of pubertal onset, associated with distichiasis. Causative mutations have now been described in FOXC2, a forkhead transcription factor gene. Numerous clinical associations have been reported with this condition, including congenital heart disease, ptosis, varicose veins, cleft palate, and spinal extradural cysts.

Subjects: We report clinical findings in 74 affected subjects from 18 families and six isolated cases. All of them were shown to have mutations in FOXC2 with the exception of one family who had two affected subjects with lymphoedema and distichiasis and linkage consistent with the 16q24 locus.

Results: The presence of lymphoedema was highly penetrant. Males had an earlier onset of lymphoedema and a significantly increased risk of complications. Lymphatic imaging confirmed the earlier suggestion that LD is associated with a normal or increased number of lymphatic vessels rather than the hypoplasia or aplasia seen in other forms of primary lymphoedema. Distichiasis was 94.2% penetrant, but not always symptomatic. Associated findings included ptosis (31%), congenital heart disease (6.8%), and cleft palate (4%). Other than distichiasis, the most commonly occurring anomaly was varicose veins of early onset (49%). This has not been previously reported and suggests a possible developmental role for FOXC2 in both venous and lymphatic systems. This is the first gene that has been implicated in the aetiology of varicose veins.

Conclusion: Unlike previous publications, the thorough clinical characterisation of our patients permits more accurate prediction of various phenotypic abnormalities likely to manifest in subjects with FOXC2 mutations.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.